All In MedTech

FDA Clearance Tracker · P030017-S338

WaveWriter Alpha Spinal Cord Stimulator (SCS) System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 1, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 1, 2020

Approved

Time to decision

222 days

Received Apr 23, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P030017-S338
Device name
WaveWriter Alpha Spinal Cord Stimulator (SCS) System
Applicant location
Valencia, CA
Received
Apr 23, 2020
Decided
Dec 1, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P030017

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

The WaveWriter Alpha Spinal Cord Stimulator (SCS) System.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.